Legal Representation
Attorney
GABRIELLE S. ROTH
USPTO Deadlines
Next Deadline
1097 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-11-06)
Due Date
November 06, 2028
Grace Period Ends
May 06, 2029
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 13, 2025 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| May 13, 2025 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| May 13, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 23, 2024 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Nov 6, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 30, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 30, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 21, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 21, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 16, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 16, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 6, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 2, 2018 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 1, 2018 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 20, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 20, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 20, 2018 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Sep 17, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 20, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 20, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 20, 2018 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Aug 20, 2018 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Aug 20, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 20, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 26, 2018 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Feb 20, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 16, 2018 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Feb 6, 2018 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Dec 26, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 26, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 6, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 14, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 14, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 14, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 14, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 14, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 9, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 8, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 8, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 24, 2017 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Jul 24, 2017 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Jul 24, 2017 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Jul 17, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 28, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 25, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biological drugs for use in treating cancer [ , and autoimmunity ] ; therapeutic [ and medical diagnostic ] agents and preparations for use in therapies and diagnosis for cancer [ , and autoimmunity ] ; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies [ and medical diagnosis ] for cancer [ , and autoimmunity ] ; therapeutic [ and diagnostic ] agents, preparations and substances for medical purposes for targeting application to immune system, cells [ , or genes ] ; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic [ and diagnostic ] agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic [ and medical diagnostic ] agents, preparations and substances in the field of cancer, [ and autoimmunity ] for medical purposes
First Use Anywhere:
Jul 19, 2017
First Use in Commerce:
Jul 19, 2017
Classification
International Classes
005